Abstract:Immunosuppressants are widely used for treatment of T cell-mediated autoimmune diseases and allogeneic graft rejection. However, because of the toxicity and tolerance of these drugs, novel immunosuppressants are urgently needed. We synthesized a series of novel water-soluble benzothiazole derivatives and found that BD926 [sodium 2-(benzo[d]thiazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-olate] had potent immunosuppressive activity. Treatment with BD926 significantly inhibited anti-CD3/anti-CD28 and alloantigen-induced human T cell proliferation as well as IL2-stimulated activated T cell proliferation in a dose-dependent manner in vitro. BD926 had no obvious cytotoxicity against human resting T cells, IL-4 treated activated T cells and fibroblast-like synoviocytes in our experimental conditions. Furthermore, BD926 induced cell cycle arrest at G0/G1 phase and inhibited the cyclin D3 and CDK 6 expression in activated T cells. BD926 inhibited the STAT5, but not Akt and p70S6K, phosphorylation in a dose-dependent manner in the IL-2-treated activated T cells. Interestingly, BD926 inhibited IFN-γ, IL-6 and IL-17, but not IL-2, IL-4 and IL-10, production in activated T cells. Finally, treatment with BD926 reduced delayed-type hypersensitivity in mice in a dose-dependent manner. Collectively, these data suggest that BD926 may be a lead compound for the design and development of new immunosuppressants for the intervention of allograft rejection and autoimmune diseases.

Synthesis and Immunosuppressive Activity of New Amino Alcohols Derivatives(Ii)

Synthesis of N-substituted iminosugar derivatives and their immunosuppressive activities

Synthetic N-alkylated iminosugars as new potential immunosuppressive agents.

Synthesis and Biological Evaluation of N-Arylated-Lactam-Type Iminosugars As Potential Immunosuppressive Agents

Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.

Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives

Synthesis of N-Dialkylphosphoryl Iminosugar Derivatives and Their Immunosuppressive Activities

Synthesis of N‐Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities

N-Arylated-Lactam-Type Iminosugars As New Immunosuppressive Agents: Discovery, Optimization, and Biological Evaluation

Design, Synthesis, and Biological Evaluation of Chalcone Oxime Derivatives As Potential Immunosuppressive Agents

Design and Syntheses of Some Iminosugar Derivatives As Potential Immunosuppressants

Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.

Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents

Synthetic Iminosugar Derivatives As New Potential Immunosuppressive Agents

(E)-1,3-diphenyl-1h-pyrazole Derivatives Containing O-benzyl Oxime Moiety As Potential Immunosuppressive Agents: Design, Synthesis, Molecular Docking and Biological Evaluation.

Synthesis and evaluation of a novel series of quinoline derivatives with immunosuppressive activity.

Synthesis and Biological Activities of Amino Acids Functionalized Α-Galcer Analogues.

Synthesis of novel cinnamanilides as potential immunosuppressive agents.

A Novel Water-Soluble Benzothiazole Derivative BD926 Inhibits Human Activated T Cell Proliferation by Down-Regulating the STAT5 Activation.

Synthesis, Crystal Structure and Immunosuppressive Activity of Acylamide Derivatives Containing 1,4-Benzodioxan.

Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents